Compounds > 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-08-23

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and sirolimus

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with sirolimus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, HS; Cho, MH; Eu, GJ; Kang, GM; Kim, H; Kim, HW; Kim, JS; Lee, KH; Moon, SH; Park, JH1
Dennis, PA; Fox, SD; Granville, CA; Hollander, MC; Issaq, HJ; Linnoila, RI; Robertson, M; Tsurutani, J; Veenstra, TD; Warfel, N1
Biddick, L; Kopelovich, L; Kumar, G; Lightfoot, S; Madka, V; Mohammed, A; Patlolla, JM; Qian, L; Rao, CV; Sadeghi, M; Zhang, Y1

Other Studies

3 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and sirolimus

ArticleYear
Cap-independent protein translation is initially responsible for 4-(N-methylnitrosamino)-1-(3-pyridyl)-butanone (NNK)-induced apoptosis in normal human bronchial epithelial cells.
    Journal of veterinary science, 2004, Volume: 5, Issue:4

    Topics: Antibiotics, Antineoplastic; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Bronchi; Carcinogens; Carrier Proteins; Caspases; Cytochromes c; Dose-Response Relationship, Drug; Epithelial Cells; Eukaryotic Initiation Factor-4E; Flow Cytometry; Humans; Nitrosamines; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins c-bcl-2; RNA Cap-Binding Proteins; Sirolimus; Time Factors

2004
Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Apr-01, Volume: 13, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Carcinogens; Female; Immunohistochemistry; Lung Neoplasms; Mice; Nicotiana; Nitrosamines; Phenotype; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases

2007
Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
    Oncology reports, 2015, Volume: 34, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; bcl-X Protein; Carcinogens; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Nicotiana; Nicotine; Nitrosamines; Proliferating Cell Nuclear Antigen; Ribosomal Protein S6 Kinases, 90-kDa; Sirolimus; TOR Serine-Threonine Kinases

2015